Emily Y. Chew MD

Emily Chew is the Director of the Division of Epidemiology and Clinical Applications (DECA), at the National Eye Institute, the National Institutes of Health in Bethesda, Maryland. She is also the Chief of the Clinical Trials Branch.  She is a medical retinal specialist with research interest in designing and conducting phase I/II/III clinical trials and epidemiologic studies in chronic retinovascular diseases such as age-related macular degeneration (AMD), diabetic retinopathy, and rare retinal diseases.  She works in large multi-centered trials including the Age-Related Eye Disease Study (AREDS) and AREDS2, focused on intermediate and late AMD, and the AMD Ryan Initiative Study (ARIS) focused on early AMD.  She chaired the ACCORD eye study of diabetic retinopathy.  She leads the international clinical part in Macular Telangiectasia type 2 Project.  She is also conducting research on artificial intelligence/deep learning technology for detection and predicting progression of AMD.

Emily received her medical degree and her ophthalmology training at the U. of Toronto, School of Medicine, in Toronto, Canada.  She completed her fellowship in Medical Retina at the Wilmer Eye Institute, the Johns Hopkins Medical Institutes and the U. of Nijmegen, the Netherlands. 

She had served as Medical Retina Fellowship Director 2002-2017. She previously served on the editorial board of Investigative Ophthalmology and Vision and had served as the editor of the Transactions of the American Ophthalmological Society (2011-2018).  Emily is currently a member of the editorial boards of Ophthalmology, Ophthalmology Retina, and Retina journals and serves as the editor-in-chief for Ophthalmology Science.